- Home
- / TTS Pharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
TTS Pharma financials data including stock price, CreditSafe score, and balance sheet.
Total Funding
$13.9 M
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|
| Cash | 1.0K | 2.0K | 4.0 |
| Accounts Receivable | 761.6K | 837.0K | |
| Current Assets | 762.7K | 838.9K | 4.0 |
| Total Assets | 762.7K | 838.9K | 905.9K |
| Accounts Payable | 117.2K | 219.0K | |
| Current Liabilities | 117.2K | 219.0K | 331.2K |
| Total Liabilities | 117.2K | 219.0K | 331.2K |
| Common Stock | 19.0 | 19.0 | 19.0 |
| Retained Earnings | (274.9K) | (300.5K) | (345.8K) |
| Total Equity | 645.5K | 619.9K | 574.6K |
| Financial Leverage | 1.2 | 1.4 | 1.6 |